Bieche We, Parfait B, Tozlu S, Lidereau R, Vidaud Meters: Quantitation out-of androgen receptor gene term in the sporadic nipple tumors by real-go out RT-PCR: evidence that MYC is actually a keen AR-managed gene. Carcinogenesis. 2001, twenty two (9): 1521-1526. /carcin/22.9.1521.
Bratthauer GL, Lininger RA, Man YG, Tavassoli FA: Androgen and you may estrogen receptor mRNA status when you look at the apocrine carcinomas. Diagn Mol Pathol. 2002, 11 (2): 113-118. 9606-200206000-00008.
Gatalica Z: Immunohistochemical study away from apocrine nipple lesions. Consistent over-term from androgen receptor accompanied by losing estrogen and you will progesterone receptors for the apocrine metaplasia and you can apocrine carcinoma for the situ. Pathol Res Pract. 1997, 193 (11-12): 753-758.
Am J Clin Pathol
Soreide JA, Lea OA, Varhaug JE, Skarstein A, Kvinnsland S: Androgen receptors inside operable cancer of the breast: regards to almost every other steroid hormonal receptors, correlations to help you prognostic items and predictive worth to own effectation of additive tamoxifen treatment. Eur J Surg Oncol. 1992, 18 (2): 112-118.
Bayer-Gather IB, Smoller B: Androgen receptors: a marker to increase sensitivity to own distinguishing cancer of the breast inside body metastasis away from unknown pri, thirteen (2): 119-122. /modpathol.3880021.
Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic interest and health-related ramifications. J Clin Oncol. 2000, 18 (5): 1135-1149.
Pang ST, Flores-Morales Good, Skoog L, Chuan YC, Nordstedt Grams, Pousette A: Control from matrix metalloproteinase 13 expression by the androgen when you look at the prostate disease. Oncol Associate. 2004, 11 (6): 1187-1192.
Bryan RM, Mercer RJ, Bennett RC, Rennie GC, Lie TH, Morgan FJ: Androgen receptors in breast cancer. Continue lendo →